Alexandria Venture Investments, Llc - Net Worth and Insider Trading

Alexandria Venture Investments, Llc Net Worth

The estimated net worth of Alexandria Venture Investments, Llc is at least $109 Million dollars as of 2024-05-26. Alexandria Venture Investments, Llc is the 10% Owner of Karuna Therapeutics Inc and owns about 244,447 shares of Karuna Therapeutics Inc (KRTX) stock worth over $81 Million. Alexandria Venture Investments, Llc is the 10% Owner of IDEAYA Biosciences Inc and owns about 432,384 shares of IDEAYA Biosciences Inc (IDYA) stock worth over $16 Million. Alexandria Venture Investments, Llc is also the 10% Owner of Constellation Pharmaceuticals Inc and owns about 216,304 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $7 Million. Besides these, Alexandria Venture Investments, Llc also holds Liquidia Corp (LQDA) , Metacrine Inc (MTCR) . Details can be seen in Alexandria Venture Investments, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alexandria Venture Investments, Llc has not made any transactions after 2020-09-18 and currently still holds the listed stock(s).

Transaction Summary of Alexandria Venture Investments, Llc

To

Alexandria Venture Investments, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexandria Venture Investments, Llc owns 24 companies in total, including Metacrine Inc (MTCR) , Kymera Therapeutics Inc (KYMR) , and Relay Therapeutics Inc (RLAY) among others .

Click here to see the complete history of Alexandria Venture Investments, Llc’s form 4 insider trades.

Insider Ownership Summary of Alexandria Venture Investments, Llc

Ticker Comapny Transaction Date Type of Owner
MTCR Metacrine Inc 2020-09-18 10 percent owner
KYMR Kymera Therapeutics Inc 2020-08-20 10 percent owner
RLAY Relay Therapeutics Inc 2020-07-15 10 percent owner
2020-06-11 10 percent owner
2019-05-13 10 percent owner
2020-03-11 10 percent owner
2019-10-02 10 percent owner
2019-07-02 10 percent owner
2019-05-28 10 percent owner
2019-05-08 10 percent owner
2018-07-30 10 percent owner
2018-07-23 10 percent owner
2018-05-08 10 percent owner
2017-11-15 10 percent owner
2020-12-03 10 percent owner
2021-02-04 10 percent owner
2022-01-06 10 percent owner
2021-10-21 10 percent owner
2021-05-26 10 percent owner
2020-12-03 10 percent owner
2020-03-11 10 percent owner
2023-05-29 other: See Remarks
2023-05-29 other: See Remarks
2019-10-02 10 percent owner

Alexandria Venture Investments, Llc Latest Holdings Summary

Alexandria Venture Investments, Llc currently owns a total of 5 stocks. Among these stocks, Alexandria Venture Investments, Llc owns 244,447 shares of Karuna Therapeutics Inc (KRTX) as of July 2, 2019, with a value of $81 Million and a weighting of 73.83%. Alexandria Venture Investments, Llc owns 432,384 shares of IDEAYA Biosciences Inc (IDYA) as of May 28, 2019, with a value of $16 Million and a weighting of 14.93%. Alexandria Venture Investments, Llc also owns 216,304 shares of Constellation Pharmaceuticals Inc (CNST) as of July 23, 2018, with a value of $7 Million and a weighting of 6.73%. The other 2 stocks Liquidia Corp (LQDA) , Metacrine Inc (MTCR) have a combined weighting of 4.51% among all his current holdings.

Latest Holdings of Alexandria Venture Investments, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRTX Karuna Therapeutics Inc 2019-07-02 244,447 329.83 80,625,954
IDYA IDEAYA Biosciences Inc 2019-05-28 432,384 37.71 16,305,201
CNST Constellation Pharmaceuticals Inc 2018-07-23 216,304 33.99 7,352,173
LQDA Liquidia Corp 2018-07-30 396,172 12.42 4,920,456
MTCR Metacrine Inc 2020-09-18 1,307,256 0.00 1,830

Holding Weightings of Alexandria Venture Investments, Llc


Alexandria Venture Investments, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Alexandria Venture Investments, Llc has made a total of 1 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 30,000 shares on July 2, 2019, which cost Alexandria Venture Investments, Llc around $480,000.

According to the SEC Form 4 filings, Alexandria Venture Investments, Llc has made a total of 1 transactions in IDEAYA Biosciences Inc (IDYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IDEAYA Biosciences Inc is the acquisition of 50,000 shares on May 28, 2019, which cost Alexandria Venture Investments, Llc around $500,000.

According to the SEC Form 4 filings, Alexandria Venture Investments, Llc has made a total of 0 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years. The most-recent trade in Constellation Pharmaceuticals Inc is the acquisition of 66,667 shares on July 23, 2018, which cost Alexandria Venture Investments, Llc around $1,000,000.

More details on Alexandria Venture Investments, Llc's insider transactions can be found in the Insider Trading History of Alexandria Venture Investments, Llc table.

Insider Trading History of Alexandria Venture Investments, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alexandria Venture Investments, Llc Trading Performance

GuruFocus tracks the stock performance after each of Alexandria Venture Investments, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexandria Venture Investments, Llc is -13.56%. GuruFocus also compares Alexandria Venture Investments, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexandria Venture Investments, Llc within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alexandria Venture Investments, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alexandria Venture Investments, Llc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.87
Relative Return to S&P 500(%) -0.9

Alexandria Venture Investments, Llc Ownership Network

Ownership Network List of Alexandria Venture Investments, Llc

No Data

Ownership Network Relation of Alexandria Venture Investments, Llc


Alexandria Venture Investments, Llc Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Alexandria Venture Investments, Llc is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

Over the past 18 months, Alexandria Venture Investments, Llc made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net sale of 380,605 shares made by Preston Klassen , a net purchase of 271,605 shares made by Braden Michael Leonard , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 271,605 shares were bought by its insiders, resulting in a net sale of 216,054 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Metacrine Inc Insider Transactions

No Available Data

Alexandria Venture Investments, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Alexandria Venture Investments, Llc. You might contact Alexandria Venture Investments, Llc via mailing address: 26 North Euclid Avenue, Pasadena Ca 91101.

Discussions on Alexandria Venture Investments, Llc

No discussions yet.